392 related articles for article (PubMed ID: 23530866)
1. Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review.
Jafri SH; Shi R; Mills G
BMC Cancer; 2013 Mar; 13():158. PubMed ID: 23530866
[TBL] [Abstract][Full Text] [Related]
2. Does advanced lung inflammation index (ALI) have prognostic significance in metastatic non-small cell lung cancer?
Ozyurek BA; Ozdemirel TS; Ozden SB; Erdoğan Y; Ozmen O; Kaplan B; Kaplan T
Clin Respir J; 2018 Jun; 12(6):2013-2019. PubMed ID: 29356383
[TBL] [Abstract][Full Text] [Related]
3. Advanced Lung Cancer Inflammation index: a prognostic score in patients with metastatic non-small cell lung cancer.
Bacha S; Sghaier A; Habibech S; Cheikhrouhou S; Racil H; Chaouch N; Chabbou A; Megdiche ML
Tunis Med; 2017 Novembre; 95(11):976-981. PubMed ID: 29877556
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Impact of the Advanced Lung Cancer Inflammation Index (ALI) in Metastatic Non-Small Cell Lung Cancer Treated with First Line Chemotherapy.
Chantharakhit C; Sujaritvanichpong N
Asian Pac J Cancer Prev; 2021 Apr; 22(4):1149-1156. PubMed ID: 33906307
[TBL] [Abstract][Full Text] [Related]
5. The advanced lung cancer inflammation index is an independent prognostic factor after surgical resection in patients with non-small-cell lung cancer.
Tomita M; Ayabe T; Nakamura K
Interact Cardiovasc Thorac Surg; 2018 Feb; 26(2):288-292. PubMed ID: 29049691
[TBL] [Abstract][Full Text] [Related]
6. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
[TBL] [Abstract][Full Text] [Related]
7. Survival outcome according to KRAS mutation status in newly diagnosed patients with stage IV non-small cell lung cancer treated with platinum doublet chemotherapy.
Brady AK; McNeill JD; Judy B; Bauml J; Evans TL; Cohen RB; Langer C; Vachani A; Aggarwal C
Oncotarget; 2015 Oct; 6(30):30287-94. PubMed ID: 26471290
[TBL] [Abstract][Full Text] [Related]
8. The prognostic significance of the advanced lung cancer inflammation index in patients with unresectable metastatic colorectal cancer: a retrospective study.
Shibutani M; Maeda K; Nagahara H; Fukuoka T; Matsutani S; Kimura K; Amano R; Hirakawa K; Ohira M
BMC Cancer; 2019 Mar; 19(1):241. PubMed ID: 30885163
[TBL] [Abstract][Full Text] [Related]
9. Pretreatment advanced lung cancer inflammation index (ALI) for predicting early progression in nivolumab-treated patients with advanced non-small cell lung cancer.
Shiroyama T; Suzuki H; Tamiya M; Tamiya A; Tanaka A; Okamoto N; Nakahama K; Taniguchi Y; Isa SI; Inoue T; Imamura F; Atagi S; Hirashima T
Cancer Med; 2018 Jan; 7(1):13-20. PubMed ID: 29150906
[TBL] [Abstract][Full Text] [Related]
10. Assessment of Prognostic Value of "Neutrophil to Lymphocyte Ratio" and "Prognostic Nutritional Index" as a Sytemic Inflammatory Marker in Non-small Cell Lung Cancer.
Kos FT; Hocazade C; Kos M; Uncu D; Karakas E; Dogan M; Uncu HG; Ozdemir N; Zengin N
Asian Pac J Cancer Prev; 2015; 16(9):3997-4002. PubMed ID: 25987075
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.
Diem S; Schmid S; Krapf M; Flatz L; Born D; Jochum W; Templeton AJ; Früh M
Lung Cancer; 2017 Sep; 111():176-181. PubMed ID: 28838390
[TBL] [Abstract][Full Text] [Related]
12. Advanced Lung Cancer Inflammation Index, a New Prognostic Score, Predicts Outcome in Patients With Small-Cell Lung Cancer.
He X; Zhou T; Yang Y; Hong S; Zhan J; Hu Z; Fang W; Qin T; Ma Y; Zhao Y; Cheng Z; Huang Y; Zhao H; Yang G; Zhang L
Clin Lung Cancer; 2015 Nov; 16(6):e165-71. PubMed ID: 25922292
[TBL] [Abstract][Full Text] [Related]
13. Non-Small Cell Lung Carcinoma in Women: A Retrospective Cohort Study in Indonesia.
Sutandyo N; Suratman E
Acta Med Indones; 2018 Oct; 50(4):291-298. PubMed ID: 30630993
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil-Lymphocyte Ratio Is a Prognostic Marker in Patients with Locally Advanced (Stage IIIA and IIIB) Non-Small Cell Lung Cancer Treated with Combined Modality Therapy.
Scilla KA; Bentzen SM; Lam VK; Mohindra P; Nichols EM; Vyfhuis MA; Bhooshan N; Feigenberg SJ; Edelman MJ; Feliciano JL
Oncologist; 2017 Jun; 22(6):737-742. PubMed ID: 28533476
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of the advanced lung cancer inflammation index in early-stage non-small cell lung cancer patients undergoing video-assisted thoracoscopic pulmonary resection.
Wang Y; Lin L; Ji Y; Mei X; Zhao C; Chen Y; Che G
Ann Palliat Med; 2020 May; 9(3):721-729. PubMed ID: 32312059
[TBL] [Abstract][Full Text] [Related]
16. Determinants of survival in advanced non--small-cell lung cancer in the era of targeted therapies.
Bauml J; Mick R; Zhang Y; Watt CD; Vachani A; Aggarwal C; Evans T; Langer C
Clin Lung Cancer; 2013 Sep; 14(5):581-91. PubMed ID: 23827517
[TBL] [Abstract][Full Text] [Related]
17. A Low Advanced Lung Cancer Inflammation Index Predicts a Poor Prognosis in Patients With Metastatic Non-Small Cell Lung Cancer.
Lu P; Ma Y; Kai J; Wang J; Yin Z; Xu H; Li X; Liang X; Wei S; Liang X
Front Mol Biosci; 2021; 8():784667. PubMed ID: 35096967
[No Abstract] [Full Text] [Related]
18. Neutrophil to Lymphocyte Ratio as a Prognostic Factor in European Patients with Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Treated with Tyrosine Kinase Inhibitors.
Aguiar-Bujanda D; Dueñas-Comino A; Saura-Grau S; Ros-Sanjuan L; Blanco-Sanchez MJ; Hernandez-Sosa M; Mori-De Santiago M; Galvan-Ruiz S; Lorenzo-Barreto JE; Vargas-Prado AM; Bohn-Sarmiento U
Oncol Res Treat; 2018; 41(12):755-761. PubMed ID: 30419558
[TBL] [Abstract][Full Text] [Related]
19. Can we define any marker associated with brain failure in patients with locally advanced non-small cell lung cancer?
Sert F; Cosgun G; Yalman D; Ozkok S
Cancer Radiother; 2021 Jun; 25(4):316-322. PubMed ID: 33422415
[TBL] [Abstract][Full Text] [Related]
20. Prognostic models to predict survival in patients with advanced non-small cell lung cancer treated with first-line chemo- or targeted therapy.
Berardi R; Rinaldi S; Santoni M; Newsom-Davis T; Tiberi M; Morgese F; Caramanti M; Savini A; Ferrini C; Torniai M; Fiordoliva I; Bower M; Cascinu S
Oncotarget; 2016 May; 7(18):26916-24. PubMed ID: 27029035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
